299 related articles for article (PubMed ID: 38172594)
1. Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications.
Jung I; Shin S; Baek MC; Yea K
Exp Mol Med; 2024 Feb; 56(1):19-31. PubMed ID: 38172594
[TBL] [Abstract][Full Text] [Related]
2. Exosome-based immunotherapy: a promising approach for cancer treatment.
Xu Z; Zeng S; Gong Z; Yan Y
Mol Cancer; 2020 Nov; 19(1):160. PubMed ID: 33183286
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy.
Tang Q; Yang S; He G; Zheng H; Zhang S; Liu J; Wei S; Fan Q; Peng X; Li X; Zhang D; Yang L; Li H
Cancer Lett; 2022 Nov; 548():215823. PubMed ID: 35835409
[TBL] [Abstract][Full Text] [Related]
4. Engineered exosomes from different sources for cancer-targeted therapy.
Zhang M; Hu S; Liu L; Dang P; Liu Y; Sun Z; Qiao B; Wang C
Signal Transduct Target Ther; 2023 Mar; 8(1):124. PubMed ID: 36922504
[TBL] [Abstract][Full Text] [Related]
5. Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation.
Castillo-Peña A; Molina-Pinelo S
Front Immunol; 2023; 14():1279495. PubMed ID: 37915578
[TBL] [Abstract][Full Text] [Related]
6. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.
Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L
Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837
[TBL] [Abstract][Full Text] [Related]
7. Biology and function of exosomes in tumor immunotherapy.
Liu C; Xia C; Xia C
Biomed Pharmacother; 2023 Dec; 169():115853. PubMed ID: 37951023
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the exosome-induced immune response for cancer immunotherapy.
Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
[TBL] [Abstract][Full Text] [Related]
9. Exosomes Function in Tumor Immune Microenvironment.
Huang Y; Liu K; Li Q; Yao Y; Wang Y
Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
[TBL] [Abstract][Full Text] [Related]
10. T cell-derived exosomes in tumor immune modulation and immunotherapy.
Zhou Q; Wei S; Wang H; Li Y; Fan S; Cao Y; Wang C
Front Immunol; 2023; 14():1130033. PubMed ID: 37153615
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in exosome-based immunotherapy applied to cancer.
Xie J; Zheng Z; Tuo L; Deng X; Tang H; Peng C; Zou Y
Front Immunol; 2023; 14():1296857. PubMed ID: 38022585
[TBL] [Abstract][Full Text] [Related]
12. Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities.
Cao J; Lv G; Wei F
Clin Transl Med; 2024 Apr; 14(4):e1645. PubMed ID: 38572668
[TBL] [Abstract][Full Text] [Related]
13. Roles of exosomes in immunotherapy for solid cancers.
Lyu C; Sun H; Sun Z; Liu Y; Wang Q
Cell Death Dis; 2024 Feb; 15(2):106. PubMed ID: 38302430
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Hypoxia-Induced Exosomes on Anti-Tumor Immunity and Its Implication for Immunotherapy.
Guo W; Qiao T; Dong B; Li T; Liu Q; Xu X
Front Immunol; 2022; 13():915985. PubMed ID: 35812406
[TBL] [Abstract][Full Text] [Related]
15. Recent Advancements in the Loading and Modification of Therapeutic Exosomes.
Xu M; Yang Q; Sun X; Wang Y
Front Bioeng Biotechnol; 2020; 8():586130. PubMed ID: 33262977
[TBL] [Abstract][Full Text] [Related]
16. OX40L-expressing M1-like macrophage exosomes for cancer immunotherapy.
Yu Y; Li T; Ou M; Luo R; Chen H; Ren H; Li Z; Sun J; Zhang H; Peng S; Zhao Y; Mei L
J Control Release; 2024 Jan; 365():469-479. PubMed ID: 38040340
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy Using Oxygenated Water and Tumor-Derived Exosomes Potentiates Antitumor Immune Response and Attenuates Malignancy Tendency in Mice Model of Breast Cancer.
Pakravan N; Abbasi A; Hassan ZM
Oxid Med Cell Longev; 2021; 2021():5529484. PubMed ID: 34194604
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies.
Li J; Li J; Peng Y; Du Y; Yang Z; Qi X
J Control Release; 2023 Jan; 353():423-433. PubMed ID: 36470333
[TBL] [Abstract][Full Text] [Related]
19. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
20. Exosomes-based cell-free cancer therapy: a novel strategy for targeted therapy.
Dutta A
Immunol Med; 2021 Jun; 44(2):116-123. PubMed ID: 32924880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
